BIOR - Biora Therapeutics Inc
IEX Last Trade
0.6973
0.012 1.649%
Share volume: 81,309
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.69
0.01
1.68%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-15 | 2022-11-14 | 2023-03-30 | 2023-05-15 | 2023-08-14 | 2023-11-13 | 2024-04-01 | 2024-05-15 | |
Total revenue | 104.000 K | 80.000 K | 14.000 K | 2.000 K | 2.000 K | 0.000 | 0.000 | 542.000 K | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 104.000 K | 80.000 K | 14.000 K | 2.000 K | 2.000 K | 0.000 | 0.000 | 542.000 K | |
-23.08% | -82.50% | -85.71% | 0.00% | -100.00% | nan% | inf% | |||
Operating expenses | 14.314 M | 13.967 M | 13.790 M | 15.546 M | 14.936 M | 23.321 M | 13.344 M | 16.058 M | |
Selling general and admin | 8.410 M | 8.147 M | 8.023 M | 8.356 M | 8.953 M | 12.774 M | 7.226 M | 9.053 M | |
Research and development | 5.904 M | 5.820 M | 5.767 M | 7.190 M | 5.983 M | 10.547 M | 6.118 M | 7.005 M | |
Total expenses | 14.314 M | 13.967 M | 13.790 M | 15.546 M | 14.936 M | 23.321 M | 13.344 M | 16.058 M | |
-2.42% | -1.27% | 12.73% | -3.92% | 56.14% | -42.78% | 20.34% | |||
Operating income | -14.210 M | -13.887 M | -13.776 M | -15.544 M | -14.934 M | -23.321 M | -13.344 M | -15.516 M | |
Ebit | -14.210 M | -13.887 M | -13.776 M | -15.544 M | -14.934 M | -23.321 M | -13.344 M | -15.516 M | |
Pretax income | -6.834 M | -14.716 M | -13.210 M | -17.441 M | -17.803 M | -73.453 M | -15.727 M | -4.141 M | |
115.34% | -10.23% | 32.03% | 2.08% | 312.59% | -78.59% | -73.67% | |||
Income tax | -837.000 K | 158.000 K | 259.000 K | 0.000 | 4.000 K | 1.000 K | -95.000 K | 48.000 K | |
Net income basic | -5.513 M | -5.114 M | -13.722 M | -17.441 M | -17.807 M | -73.454 M | -15.413 M | -4.189 M | |
7.24% | -168.32% | -27.10% | -2.10% | -312.50% | 79.02% | 72.82% | |||
Net income | -5.513 M | -5.114 M | -13.722 M | -17.441 M | -17.807 M | -73.454 M | -15.413 M | -4.189 M | |
7.24% | -168.32% | -27.10% | -2.10% | -312.50% | 79.02% | 72.82% |